Review article · 2018 · Open access

Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?

Luca Parisi, Elisabetta Gini, Denisa Baci, Marco Tremolati, Matteo Fanuli, Barbara Bassani, Giampietro Farronato, Antonino Bruno, Lorenzo Mortara

Journal of Immunology Research, 2018, 1–25 · Published 1 January 2018 · DOI 10.1155/2018/8917804

Free PDFView at the publisherCite this paper

In brief

“Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?” is a 2018 review article by Luca Parisi and 8 co-authors, published in Journal of Immunology Research. OpenAlex counts 530 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at Journal of Immunology Research.

Citations
530
Most cited in
2023 (90)
Field-weighted impact
4.89
References
276
Authors
9

Abstract

Macrophages are key cellular components of the innate immunity, acting as the main player in the first-line defence against the pathogens and modulating homeostatic and inflammatory responses. Plasticity is a major feature of macrophages resulting in extreme heterogeneity both in normal and in pathological conditions. Macrophages are not homogenous, and they are generally categorized into two broad but distinct subsets as either classically activated (M1) or alternatively activated (M2). However, macrophages represent a continuum of highly plastic effector cells, resembling a spectrum of diverse phenotype states. Induction of specific macrophage functions is closely related to the surrounding environment that acts as a relevant orchestrator of macrophage functions. This phenomenon, termed polarization, results from cell/cell, cell/molecule interaction, governing macrophage functionality within the hosting tissues. Here, we summarized relevant cellular and molecular mechanisms driving macrophage polarization in "distant" pathological conditions, such as cancer, type 2 diabetes, atherosclerosis, and periodontitis that share macrophage-driven inflammation as a key feature, playing their dual role as killers (M1-like) and/or builders (M2-like). We also dissect the physio/pathological consequences related to macrophage polarization within selected chronic inflammatory diseases, placing polarized macrophages as a relevant hallmark, putative biomarkers, and possible target for prevention/therapy.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Parisi, L., Gini, E., Baci, D., Tremolati, M., Fanuli, M., Bassani, B., Farronato, G., Bruno, A., & Mortara, L. (2018). Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders? Journal of Immunology Research, 2018, 1–25. https://doi.org/10.1155/2018/8917804

MLA 9

Parisi, Luca, et al. “Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?” Journal of Immunology Research, vol. 2018, 2018, pp. 1–25. https://doi.org/10.1155/2018/8917804.

Chicago

Parisi, Luca, Elisabetta Gini, Denisa Baci, Marco Tremolati, Matteo Fanuli, Barbara Bassani, Giampietro Farronato, Antonino Bruno, and Lorenzo Mortara. 2018. “Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?” Journal of Immunology Research 2018: 1–25. https://doi.org/10.1155/2018/8917804.

Harvard

Parisi, L. et al. (2018) ‘Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?’, Journal of Immunology Research, 2018, pp. 1–25. doi:10.1155/2018/8917804.

IEEE

L. Parisi et al., “Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?,” Journal of Immunology Research, vol. 2018, pp. 1–25, 2018, doi: 10.1155/2018/8917804.

BibTeX

@article{parisi2018macrophage,
  title     = {{Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?}},
  author    = {Parisi, Luca and Gini, Elisabetta and Baci, Denisa and Tremolati, Marco and Fanuli, Matteo and Bassani, Barbara and Farronato, Giampietro and Bruno, Antonino and Mortara, Lorenzo},
  journal   = {Journal of Immunology Research},
  year      = {2018},
  volume    = {2018},
  pages     = {1--25},
  doi       = {10.1155/2018/8917804},
  url       = {https://doi.org/10.1155/2018/8917804}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201711
20181818
20195050
20206464
20216565
20227070
20239090
20246666
20257272
20263434

Its field-weighted citation impact is 4.89: it has been cited 4.89 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer

  • macrophage polarization
  • chronic inflammation
  • macrophage heterogeneity
  • macrophage plasticity
  • cancer-associated macrophages
  • type 2 diabetes
  • atherosclerosis
  • periodontitis

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Parisi, L., Gini, E., Baci, D., Tremolati, M., Fanuli, M., Bassani, B., Farronato, G., Bruno, A., & Mortara, L. (2018). Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders? Journal of Immunology Research, 2018, 1–25. https://doi.org/10.1155/2018/8917804

How many times has this paper been cited?

530 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Journal of Immunology Research.

Who wrote this paper?

Luca Parisi, Elisabetta Gini, Denisa Baci, Marco Tremolati, Matteo Fanuli, Barbara Bassani, Giampietro Farronato, Antonino Bruno, Lorenzo Mortara.

What is the DOI of this paper?

10.1155/2018/8917804. The permanent link is https://doi.org/10.1155/2018/8917804.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.